BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31147264)

  • 21. The STK11/LKB1 Peutz-Jegher gene is not involved in the pathogenesis of sporadic sex cord-stromal tumors, although loss of heterozygosity at 19p13.3 indicates other gene alteration in these tumors.
    Kato N; Romero M; Catasus L; Prat J
    Hum Pathol; 2004 Sep; 35(9):1101-4. PubMed ID: 15343512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed germ cell sex cord-stromal tumors of the testis and ovary. Morphological, immunohistochemical, and molecular genetic study of seven cases.
    Michal M; Vanecek T; Sima R; Mukensnabl P; Hes O; Kazakov DV; Matoska J; Zuntova A; Dvorak V; Talerman A
    Virchows Arch; 2006 May; 448(5):612-22. PubMed ID: 16538443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the histogenesis of mixed germ cell-sex cord stromal tumour of the gonads.
    Roth LM; Cheng L
    J Clin Pathol; 2017 Mar; 70(3):222-227. PubMed ID: 27458149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Genomic Profiling of Adult Renal Sarcomas Provides Insight into Disease Biology and Opportunities for Targeted Therapies.
    Yakirevich E; Madison R; Fridman E; Mangray S; Carneiro BA; Lu S; Cooke M; Bratslavsky G; Webster J; Ross JS; Ali SM
    Eur Urol Oncol; 2021 Apr; 4(2):282-288. PubMed ID: 31412008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
    Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
    Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of beta-catenin mutation and SOX9 expression in sex cord-stromal tumours of the testis.
    Bremmer F; Behnes CL; Schildhaus HU; Gaisa NT; Reis H; Jarry H; Radzun HJ; Stroebel P; Schweyer S
    Virchows Arch; 2017 Apr; 470(4):421-428. PubMed ID: 28204871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy.
    Kang H; Pettinga D; Schubert AD; Ladenson PW; Ball DW; Chung JH; Schrock AB; Madison R; Frampton GM; Stephens PJ; Ross JS; Miller VA; Ali SM
    Oncologist; 2019 Jun; 24(6):791-797. PubMed ID: 30373905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive Assessment of Immuno-oncology Biomarkers in Adenocarcinoma, Urothelial Carcinoma, and Squamous-cell Carcinoma of the Bladder.
    Necchi A; Madison R; Raggi D; Jacob JM; Bratslavsky G; Shapiro O; Elvin JA; Vergilio JA; Killian JK; Ngo N; Ramkissoon S; Severson E; Hemmerich AC; Huang R; Ali SM; Chung JH; Reddy P; Miller VA; Schrock AB; Gay LM; Alexander BM; Grivas P; Ross JS
    Eur Urol; 2020 Apr; 77(4):548-556. PubMed ID: 31959546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
    Young RH
    Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy.
    Hacking SM; Pavlick D; Wang Y; Carneiro BA; Mullally M; Lu S; Canepa M; Bratslavsky G; Jacob J; Necchi A; Spiess PE; Wang L; Yakirevich E; Ross J
    Oncologist; 2023 Jul; 28(7):e508-e519. PubMed ID: 36917021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads.
    Bulun SE; Rosenthal IM; Brodie AM; Inkster SE; Zeller WP; DiGeorge AM; Frasier SD; Kilgore MW; Simpson ER
    J Clin Endocrinol Metab; 1994 Feb; 78(2):1616-21. PubMed ID: 8106605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart.
    Necchi A; Bratslavsky G; Chung J; Millis S; Gay LM; Ali SM; Ross JS
    Oncologist; 2019 Apr; 24(4):e142-e145. PubMed ID: 30659078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of galectin-3 in gonads and gonadal sex cord stromal and germ cell tumors.
    Devouassoux-Shisheboran M; Deschildre C; Mauduit C; Berger G; Mejean-Lebreton F; Bouvier R; Droz JP; Fénichel P; Benahmed M
    Oncol Rep; 2006 Aug; 16(2):335-40. PubMed ID: 16820912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sex cord gonadal stromal tumors].
    Bremmer F; Behnes CL; Radzun HJ; Bettstetter M; Schweyer S
    Pathologe; 2014 May; 35(3):245-51. PubMed ID: 24819979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic changes in nonepithelial ovarian cancer.
    Van Nieuwenhuysen E; Lambrechts S; Lambrechts D; Leunen K; Amant F; Vergote I
    Expert Rev Anticancer Ther; 2013 Jul; 13(7):871-82. PubMed ID: 23875665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study.
    Lee H; El Jabbour T; Ainechi S; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon SH; Ali SM; Schrock A; Fabrizio D; Frampton G; Nazeer T; Miller VA; Stephens PJ; Ross JS
    Hum Pathol; 2017 Dec; 70():84-91. PubMed ID: 29079173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study.
    Necchi A; Spiess PE; Bandini M; Basile G; Grivas P; Bratslavsky G; Jacob J; Danziger N; Lin D; Decker B; Sokol ES; Huang RSP; Kulkarni SB; Ross JS
    Oncologist; 2022 Dec; 27(12):1016-1024. PubMed ID: 35881043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
    Mosharafa AA; Foster RS; Bihrle R; Koch MO; Ulbright TM; Einhorn LH; Donohue JP
    Cancer; 2003 Aug; 98(4):753-7. PubMed ID: 12910519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroidogenic acute regulatory protein is a useful marker for Leydig cells and sex-cord stromal tumors.
    Dong L; Wang H; Su Z; Niu S; Wang R; Wu L; Chen G
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):226-32. PubMed ID: 21217523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
    Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
    Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.